Dr. John P. Salerno Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor
October 19 2017 - 10:00AM
Access Wire
HICKSVILLE, NY / ACCESSWIRE / October 19, 2017
/ Canbiola, Inc. (OTC PINK: CANB), in it's continuing
effort to partner with the top people in the global health and
wellness field, announced today that the company has added Dr. John
P. Salerno to its Medical Advisory Board. Dr. Salerno was also
signed as a distributor for Canbiola products. Dr. Salerno will
utilize and distribute Canbiola products through his network of
clinics globally, including the US, Japan, and Brazil. As a pioneer
in the International practice of complementary medicine, Dr.
Salerno will help guide the Company in the development of new and
innovative products and delivery systems. Dr. Salerno stated,"I am
very excited to join the Canbiola team in selling the finest and
purest form of Hemp derived CBD. This can be a game-changer in
treating my patients with potentially many medical
applications."
Marco Alfonsi, Canbiola CEO, stated, "We are continuing to
execute our plan to strengthen not only our Medical Advisory Board
but also our distribution network. With the addition of Dr.
Salerno, we have added our ability to reach a global market for our
products. The company has already seen the benefits of this
strategy with better than expected results from previously added
medical advisors, and I have no doubt that this last addition will
further grow both sales and geographically expand our client
base."
About Dr. John P. Salerno
Dr. John P. Salerno is an international pioneer in the practice
of complementary medicine. Among many other accomplishments, he is
well-known for his vitamin IV suites, weight-loss treatments, and
chelation therapy, a therapy that removes heavy metals from the
body.
The Salerno Center for Complementary Medicine in New York City
combines the wisdom of alternative healing with the teachings of
traditional medicine, helping patients to live healthier and
happier lives.
After the terrorist bombings of September 11, 2001, Dr. Salerno
served as the Medical Director for the World Trade Center Landfill,
a position that earned him a commendation from the then-mayor, Rudy
Giuliani.
Furthermore, he was charged with monitoring the health of public
workers assigned to manage the massive landfill, as much of the
debris from the World Trade Center was riddled with airborne
chemicals, heavy metals, and toxic buildup.
Dr. Salerno has founded and guides many medical clinics
internationally, including seven in Tokyo, two in Brazil, and two
in the US. In addition, he personally trains physicians worldwide.
He has served as a clinical preceptor at the Yale University School
of Medicine, as well as the Medical Director of St. Vincent's
Immediate Health Care in Shelton, Connecticut.
Dr. Salerno is a much sought-after expert in the field of health
and wellness. He has been interviewed by many media outlets,
including local news, Fox Business, and Telemundo, among
others.
About Canbiola, Inc.
Canbiola, Inc. is a public company trading under symbol CANB.
The company's focus is in the sale of a variety of Cannabidiol
(CBD) based products derived from legally imported Hemp. Canbiola
is in the process of developing its own line of proprietary
products, as well as seeking synergistic value through acquisitions
in the CBD and the medical cannabis industry. The company has
already launched several products found at www.canbiola.com.
Cannabis is currently federally illegal and has been legalized for
medical purposes in varying forms in only a limited number of
states.
The company also owns two technological solutions, "WRAPmail"
(US Patent 8,572,275), which turns traditional email into a
powerful marketing and branding tool, and "Prosperity Systems" and
the "Bullseye" platform of document management and compliance
targeted at broker-dealers, public companies, and governmental
agencies providing a flawless all-in-one solution for document
management, retention and compliance.
Forward-Looking Statements and Risks and
Uncertainties:
Matters discussed in this press release contain forward-looking
statements. The words "anticipate," "believe," "estimate," "may,"
"intend," "expect," and similar expressions identify such
forward-looking statements. Expected results, actual results,
performance, or achievements could differ materially from those
contemplated, expressed, or implied by the forward-looking
statements contained herein. Forward-looking statements are subject
to a number of risks and uncertainties, including but not limited
to, risks and uncertainties associated with, among other things,
the impact of economic, competitive, and other factors affecting
our operations, markets, products, and performance. The matters
discussed herein should not be construed in any way, shape or
manner of our future financial condition or stock price. We do not
undertake to update any statement should actual result differ from
the forward-looking statement.
For complete information regarding our business at Canbiola:
Twitter
Facebook
Canbiola Investor Relations
IR@canbiola.com
Phone 516-544-8219
http://www.canbiola.com
SOURCE: Canbiola Inc.
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Aug 2024 to Sep 2024
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Sep 2023 to Sep 2024